Granted Patent
B2
US 7,074,895 · App. 09/802,472 · Granted Jul 11, 2006
Sequences characteristic of hypoxia-regulated gene transcription
View Patent ↗
Loading inventors, assignments & file history…
Abstract
There are provided polynucleotides which are modulated by hypoxic conditions. The disclosure includes such genes and proteins as well as analogs, salts and functional derivatives of such proteins, and DNA encoding such analogs, and methods of use. Methods for treating the effects of stroke, hypoxia and/or ischemia by regulating such genes or proteins are also disclosed. The presence of hypoxia or a hypoxia-associated pathology may be diagnosed by screening for the presence of at least one polynucleotide having the nucleic acid sequence according to the present invention. Methods of regulating hypoxia associated pathologies are also provided.
Claims (1)
1. An isolated polypeptide comprising SEQ ID NO:4.
Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 7, 2008
From: KALINSKI, HAGAR
To: QUARK PHARMACEUTICALS, INC.
Reel/Frame 021640/0280 →
CHANGE OF NAME
Recorded Oct 7, 2008
From: QUARK BIOTECH, INC.
To: QUARK PHARMACEUTICALS, INC.
Reel/Frame 021658/0408 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 6, 2004
From: REGEV, AVIV
To: QUARK BIOTECH, INC.
Reel/Frame 014816/0386 →